Kalaris Therapeutics Inc
USD4.17
-0.05 (-1.09%)
CEO
Andrew Oxtoby
IPO Date
2020-07-30
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.28
Prev. Close
$4.21
Day Low
$4.17
Day High
$4.32
52W Low
$2.14
52W High
$11.88
Market Cap
$0.08B
Volume
0.00M
| 9,000 |
| $4.72 |
| 4 Jun 2026 | Hallal David | director | A-Award | Acquired | 9,000 | $4.72 |
| 4 Jun 2026 | AKKARAJU SRINIVAS | director | A-Award | Acquired | 9,000 | $4.72 |
| 4 Jun 2026 | Dybbs Michael | director | A-Award | Acquired | 9,000 | $4.72 |
| 4 Jun 2026 | ADAMIS ANTHONY P | director | A-Award | Acquired | 9,000 | $4.72 |
| 4 Jun 2026 | PATTERSON LEONE D | director | A-Award | Acquired | 9,000 | $4.72 |
| 22 May 2026 | AKKARAJU SRINIVAS | director, 10 percent owner: | P-Purchase | Acquired | 244,300 | $4.83 |
| 22 May 2026 | AKKARAJU SRINIVAS | director, 10 percent owner: | J-Other | Disposed | 66,906 | $0.00 |
| 22 May 2026 | AKKARAJU SRINIVAS | director, 10 percent owner: | J-Other | Acquired | 14,937 | $0.00 |